Functional and mechanism experiments revealed that TRPM2 promotes ccRCC progression by promoting EMT via reducing ER stress, and knock-out of TRPM2 can reverse the phenotype. The gene discussed is TRPM2; the disease is nonpapillary renal cell carcinoma.